• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NMDARs与铁之间相互作用的新见解:对理解神经疾病病理学的启示

New Insights into the Crosstalk between NMDARs and Iron: Implications for Understanding Pathology of Neurological Diseases.

作者信息

Xu Huamin, Jiang Hong, Xie Junxia

机构信息

Collaborative Innovation Center for Brain Science, Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders and State Key Disciplines: Physiology, Medical College of Qingdao UniversityQingdao, China; Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Qingdao UniversityQingdao, China.

出版信息

Front Mol Neurosci. 2017 Mar 16;10:71. doi: 10.3389/fnmol.2017.00071. eCollection 2017.

DOI:10.3389/fnmol.2017.00071
PMID:28360837
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5352910/
Abstract

Both iron dyshomeostasis and N-methyl-D-aspartate receptors (NMDARs)-mediated neurotoxicity have been shown to have an important role in neurological diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD). Evidence proved that activation of NMDARs could promote iron overload and iron-induced neurotoxicity by enhancing iron importer divalent metal transporter 1 (DMT1)-mediated iron uptake and iron releasing from lysosome. Also, iron overload could regulate NMDARs-mediated synaptic transmission. This indicates that there might be a possible relationship between iron and activation of NMDARs in neurological diseases. Understanding this interaction between iron and activation of NMDARs may provide new therapeutic avenues for a more targeted neurotherapeutic strategy for these diseases. Therefore, in this review article, we will describe the dysfunction of iron metabolism and NMDARs in neurological diseases including PD and AD, and summarize the new insight into the mechanisms underlying the interaction between iron and activation of NMDARs.

摘要

铁稳态失衡和N-甲基-D-天冬氨酸受体(NMDARs)介导的神经毒性在帕金森病(PD)和阿尔茨海默病(AD)等神经疾病中均发挥重要作用。有证据表明,NMDARs的激活可通过增强铁转运体二价金属离子转运体1(DMT1)介导的铁摄取以及铁从溶酶体的释放,从而促进铁过载和铁诱导的神经毒性。此外,铁过载可调节NMDARs介导的突触传递。这表明在神经疾病中铁与NMDARs的激活之间可能存在某种联系。了解铁与NMDARs激活之间的这种相互作用,可能为这些疾病更具针对性的神经治疗策略提供新的治疗途径。因此,在这篇综述文章中,我们将描述包括PD和AD在内的神经疾病中铁代谢和NMDARs的功能障碍,并总结关于铁与NMDARs激活之间相互作用机制的新见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f061/5352910/da2ed15caf98/fnmol-10-00071-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f061/5352910/da2ed15caf98/fnmol-10-00071-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f061/5352910/da2ed15caf98/fnmol-10-00071-g0001.jpg

相似文献

1
New Insights into the Crosstalk between NMDARs and Iron: Implications for Understanding Pathology of Neurological Diseases.NMDARs与铁之间相互作用的新见解:对理解神经疾病病理学的启示
Front Mol Neurosci. 2017 Mar 16;10:71. doi: 10.3389/fnmol.2017.00071. eCollection 2017.
2
NMDARs in neurological diseases: a potential therapeutic target.神经疾病中的N-甲基-D-天冬氨酸受体:一个潜在的治疗靶点。
Int J Neurosci. 2015 May;125(5):315-27. doi: 10.3109/00207454.2014.940941. Epub 2014 Jul 30.
3
Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease.在阿尔茨海默病PS2APP小鼠模型早期病理过程中,GluN2B N-甲基-D-天冬氨酸受体功能及突触可塑性的改变
Neurobiol Dis. 2015 Feb;74:254-62. doi: 10.1016/j.nbd.2014.11.017. Epub 2014 Dec 4.
4
Brain Iron Metabolism Dysfunction in Parkinson's Disease.帕金森病中的脑铁代谢功能障碍。
Mol Neurobiol. 2017 May;54(4):3078-3101. doi: 10.1007/s12035-016-9879-1. Epub 2016 Apr 2.
5
Dysfunctional synapse in Alzheimer's disease - A focus on NMDA receptors.阿尔茨海默病中的功能障碍突触——聚焦于 NMDA 受体。
Neuropharmacology. 2014 Jan;76 Pt A:16-26. doi: 10.1016/j.neuropharm.2013.08.013. Epub 2013 Aug 22.
6
GluN2D-containing NMDA receptors inhibit neurotransmission in the mouse striatum through a cholinergic mechanism: implication for Parkinson's disease.谷氨酸 N-甲基-D-天冬氨酸受体 2D 亚型包含的 NMDA 受体通过胆碱能机制抑制小鼠纹状体的神经传递:对帕金森病的影响。
J Neurochem. 2014 May;129(4):581-90. doi: 10.1111/jnc.12658. Epub 2014 Feb 11.
7
NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.NMDA 受体介导突触抑制,但成年淀粉样β(Aβ)过表达小鼠齿状回中的棘突丢失不被介导。
Acta Neuropathol Commun. 2018 Oct 23;6(1):110. doi: 10.1186/s40478-018-0611-4.
8
Allosteric modulation of NMDA receptors alters neurotransmission in the striatum of a mouse model of Parkinson's disease.变构调节 NMDA 受体改变帕金森病小鼠模型纹状体中的神经传递。
Exp Neurol. 2014 May;255:154-60. doi: 10.1016/j.expneurol.2014.03.001. Epub 2014 Mar 12.
9
Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release.β淀粉样蛋白(Aβ)和N-甲基-D-天冬氨酸受体(NMDAR)激活会导致涉及内质网钙释放的线粒体功能障碍。
Neurobiol Aging. 2015 Feb;36(2):680-92. doi: 10.1016/j.neurobiolaging.2014.09.006. Epub 2014 Sep 6.
10
NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer's disease.轻度认知障碍和阿尔茨海默病中的NMDA神经传递功能障碍。
Curr Pharm Des. 2014;20(32):5169-79. doi: 10.2174/1381612819666140110115603.

引用本文的文献

1
Iron, Emotion, and Awareness: Exploring Alexithymia and Anxiety in Anemic Women.铁、情绪与意识:探索贫血女性的述情障碍与焦虑
Medicina (Kaunas). 2025 Jul 26;61(8):1359. doi: 10.3390/medicina61081359.
2
The role of protein phosphorylation modifications mediated by iron metabolism regulatory networks in the pathogenesis of Alzheimer's disease.铁代谢调节网络介导的蛋白质磷酸化修饰在阿尔茨海默病发病机制中的作用。
Front Aging Neurosci. 2025 Feb 25;17:1540019. doi: 10.3389/fnagi.2025.1540019. eCollection 2025.
3
Regional brain iron correlates with transcriptional and cellular signatures in Alzheimer's disease.

本文引用的文献

1
Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations.针对神经退行性疾病中突触外NMDA受体信号传导病理三联征的治疗靶点。
J Exp Med. 2017 Mar 6;214(3):569-578. doi: 10.1084/jem.20161673. Epub 2017 Feb 16.
2
Amyloid-beta peptide decreases expression and function of glutamate transporters in nervous system cells.淀粉样β肽减少神经系统细胞中谷氨酸转运体的表达和功能。
Int J Biochem Cell Biol. 2017 Apr;85:75-84. doi: 10.1016/j.biocel.2017.01.017. Epub 2017 Feb 8.
3
Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.
局部脑铁与阿尔茨海默病中的转录和细胞特征相关。
Alzheimers Dement. 2025 Jan;21(1):e14459. doi: 10.1002/alz.14459.
4
Perturbed iron biology in the prefrontal cortex of people with schizophrenia.精神分裂症患者前额叶皮层中铁生物学的紊乱。
Mol Psychiatry. 2023 May;28(5):2058-2070. doi: 10.1038/s41380-023-01979-3. Epub 2023 Feb 7.
5
Ferroptosis is involved in regulating perioperative neurocognitive disorders: emerging perspectives.铁死亡参与调控围手术期神经认知障碍:新视角。
J Neuroinflammation. 2022 Sep 6;19(1):219. doi: 10.1186/s12974-022-02570-3.
6
Rare Gain-of-Function Variant Associated with Cerebellar Ataxia, Parkinsonism, Cognitive Dysfunction, and Brain Iron Accumulation.罕见的与小脑共济失调、帕金森病、认知功能障碍和脑铁积累相关的功能获得性变异。
Int J Mol Sci. 2021 Jul 31;22(15):8247. doi: 10.3390/ijms22158247.
7
Inhibitors of Human Divalent Metal Transporters DMT1 (SLC11A2) and ZIP8 (SLC39A8) from a GDB-17 Fragment Library.从 GDB-17 片段文库中筛选出人类二价金属转运蛋白 DMT1(SLC11A2)和 ZIP8(SLC39A8)的抑制剂。
ChemMedChem. 2021 Nov 5;16(21):3306-3314. doi: 10.1002/cmdc.202100467. Epub 2021 Aug 31.
8
Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson's disease.区域脑铁与基因表达为帕金森病神经退行性变提供新视角。
Brain. 2021 Jul 28;144(6):1787-1798. doi: 10.1093/brain/awab084.
9
NMDA receptor-mediated CaMKII/ERK activation contributes to renal fibrosis.NMDA 受体介导电钙调蛋白激酶 II/细胞外信号调节激酶激活导致肾纤维化。
BMC Nephrol. 2020 Sep 9;21(1):392. doi: 10.1186/s12882-020-02050-x.
10
Psychiatric disorders risk in patients with iron deficiency anemia and association with iron supplementation medications: a nationwide database analysis.缺铁性贫血患者的精神障碍风险及与铁补充药物的关联:一项全国性数据库分析。
BMC Psychiatry. 2020 May 11;20(1):216. doi: 10.1186/s12888-020-02621-0.
轻度认知障碍中脑铁与β淀粉样蛋白的共定位
Sci Rep. 2016 Oct 17;6:35514. doi: 10.1038/srep35514.
4
Iron Deficiency Impairs Developing Hippocampal Neuron Gene Expression, Energy Metabolism, and Dendrite Complexity.缺铁会损害发育中的海马神经元基因表达、能量代谢和树突复杂性。
Dev Neurosci. 2016;38(4):264-276. doi: 10.1159/000448514. Epub 2016 Sep 27.
5
Activation of ATP-sensitive potassium channels enhances DMT1-mediated iron uptake in SK-N-SH cells in vitro.ATP 敏感性钾通道的激活增强了 SK-N-SH 细胞中 DMT1 介导的铁摄取。
Sci Rep. 2016 Sep 20;6:33674. doi: 10.1038/srep33674.
6
Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies.N-甲基-D-天冬氨酸受体介导的谷氨酸能信号在慢性和急性神经病理学中的作用
Neural Plast. 2016;2016:2701526. doi: 10.1155/2016/2701526. Epub 2016 Aug 18.
7
Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.铁转运蛋白的表达与帕金森病和阿尔茨海默病的病理特征在年轻、成年和老年大鼠大脑中的表现。
Mol Neurobiol. 2017 Sep;54(7):5213-5224. doi: 10.1007/s12035-016-0067-0. Epub 2016 Aug 30.
8
Iron overload-induced calcium signals modulate mitochondrial fragmentation in HT-22 hippocampal neuron cells.铁过载诱导的钙信号调节HT-22海马神经元细胞中的线粒体碎片化。
Toxicology. 2016 Jul 15;365:17-24. doi: 10.1016/j.tox.2016.07.022. Epub 2016 Jul 29.
9
Parkinson's Disease: The Mitochondria-Iron Link.帕金森病:线粒体与铁的联系
Parkinsons Dis. 2016;2016:7049108. doi: 10.1155/2016/7049108. Epub 2016 May 17.
10
Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC.铁死亡,帕金森病中一种新的细胞死亡形式,由 PKC 调控。
Neurobiol Dis. 2016 Oct;94:169-78. doi: 10.1016/j.nbd.2016.05.011. Epub 2016 May 14.